Phase 2 clinical trial of ET-02
Latest Information Update: 14 Jan 2025
Price :
$35 *
At a glance
- Drugs ET 02 Eirion Therapeutics (Primary)
- Indications Alopecia
- Focus Therapeutic Use
- 14 Jan 2025 New trial record
- 08 Jan 2025 According to an Eirion Therapeutics media release, company plans to begin this clinical trial in 2025 with with the goal of confirming safety and efficacy of ET-02.